Orchid Pharma: Company Says Establishment Inspection Report “EIR” Has Been Issued By USFDA With “VAI” Status Accepting The Company’s Submission On The Observations Raised Earlier (Positive) stock is having extended trendline support near 500 and currently trading below all important moving averages like 100 and 200.

#FundamentalViews#TechnicalViews

137 likes·54 comments